WO2008064336A8 - Autoimmune disease biomarkers - Google Patents

Autoimmune disease biomarkers

Info

Publication number
WO2008064336A8
WO2008064336A8 PCT/US2007/085432 US2007085432W WO2008064336A8 WO 2008064336 A8 WO2008064336 A8 WO 2008064336A8 US 2007085432 W US2007085432 W US 2007085432W WO 2008064336 A8 WO2008064336 A8 WO 2008064336A8
Authority
WO
WIPO (PCT)
Prior art keywords
autoimmune disease
disease biomarkers
biomarkers
autoimmune
disease
Prior art date
Application number
PCT/US2007/085432
Other languages
French (fr)
Other versions
WO2008064336A2 (en
WO2008064336A9 (en
Inventor
Dawn R Mattoon
Barry Schweitzer
David Alcorta
Dhavel Patel
Ronald Falk
Original Assignee
Inivitrogen Corp
Dawn R Mattoon
Barry Schweitzer
David Alcorta
Dhavel Patel
Ronald Falk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inivitrogen Corp, Dawn R Mattoon, Barry Schweitzer, David Alcorta, Dhavel Patel, Ronald Falk filed Critical Inivitrogen Corp
Priority to EP07868834A priority Critical patent/EP2089712A4/en
Priority to JP2009538516A priority patent/JP2010510528A/en
Publication of WO2008064336A2 publication Critical patent/WO2008064336A2/en
Publication of WO2008064336A9 publication Critical patent/WO2008064336A9/en
Publication of WO2008064336A8 publication Critical patent/WO2008064336A8/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
PCT/US2007/085432 2006-11-22 2007-11-21 Autoimmune disease biomarkers WO2008064336A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07868834A EP2089712A4 (en) 2006-11-22 2007-11-21 Autoimmune disease biomarkers
JP2009538516A JP2010510528A (en) 2006-11-22 2007-11-21 Biomarkers for autoimmune diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86702206P 2006-11-22 2006-11-22
US60/867,022 2006-11-22

Publications (3)

Publication Number Publication Date
WO2008064336A2 WO2008064336A2 (en) 2008-05-29
WO2008064336A9 WO2008064336A9 (en) 2008-07-31
WO2008064336A8 true WO2008064336A8 (en) 2008-12-18

Family

ID=39430603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/085432 WO2008064336A2 (en) 2006-11-22 2007-11-21 Autoimmune disease biomarkers

Country Status (4)

Country Link
US (2) US20080254482A1 (en)
EP (1) EP2089712A4 (en)
JP (1) JP2010510528A (en)
WO (1) WO2008064336A2 (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371388B1 (en) * 2000-05-04 2008-05-13 Human Genome Sciences, Inc. Treatment of Sjogren's syndrome by administration of TR18 polypeptides
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US8492098B2 (en) 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
EP2046809B1 (en) * 2006-07-19 2016-12-07 The Trustees Of The University Of Pennsylvania Wsx-1/il-27 as a target for anti-inflammatory responses
US20090047689A1 (en) * 2007-06-20 2009-02-19 John Kolman Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
EP3779444A1 (en) 2008-01-18 2021-02-17 President and Fellows of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
CN101983337A (en) 2008-02-04 2011-03-02 班扬生物标记公司 Process to diagnose or treat brain injury
GB2460717A (en) * 2008-06-11 2009-12-16 Sense Proteomic Ltd Autoantibodies for the detection of a predisposition to Lupus
WO2010005521A1 (en) * 2008-06-30 2010-01-14 Bltn, Llc Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
WO2010065116A2 (en) * 2008-12-02 2010-06-10 The Trustees Of The University Of Pennsylvania The use of il-27-p28 to antagonize il-6 mediated signaling
EP2336769A1 (en) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Trigger assay for differentiating between rheumatic and non-rheumatic disorders
CA2789411A1 (en) * 2010-02-12 2011-08-18 Yeda Research And Development, Co., Ltd. Diagnosis of systemic lupus erythematosus (sle)
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
JP5363663B2 (en) 2010-03-01 2013-12-11 クワンテリクス コーポレーション Method or system for extending the dynamic range in an assay to detect molecules or particles
EP2548022B1 (en) * 2010-03-18 2016-03-16 The Regents Of The University Of Michigan Multiphase microarrays and uses thereof
EP2569630A4 (en) * 2010-05-13 2013-10-30 Univ New Jersey Med Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases
CN103119179A (en) 2010-07-23 2013-05-22 哈佛大学校长及研究员协会 Methods for detecting signatures of disease or conditions in bodily fluids
EA201390149A1 (en) 2010-07-23 2013-08-30 Президент Энд Феллоуз Оф Гарвард Колледж METHODS FOR DETECTING DISEASES OR PATHOLOGICAL CONDITIONS USING PHAGOCYTARY CELLS
EP2596353A4 (en) 2010-07-23 2014-01-15 Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
WO2012021714A2 (en) * 2010-08-12 2012-02-16 William Marsh Rice University Biomarker signatures for wellness testing
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
EP2437060A1 (en) * 2010-10-01 2012-04-04 Protagen AG Marker sequences for multiple sclerosis and use of same
GB201017520D0 (en) * 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
US9310380B2 (en) * 2010-11-17 2016-04-12 National University Corporation Ehime University Method for analyzing proteins contributing to autoimmune diseases, and method for testing for said diseases
AU2012204413A1 (en) * 2011-01-05 2013-08-15 Zeus Scientific, Inc. Diagnostic methods
US20140302532A1 (en) 2011-04-12 2014-10-09 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
US20120283113A1 (en) * 2011-05-06 2012-11-08 Hyde Roderick A Compositions and methods for antibody and ligand identification
US20150133322A1 (en) * 2011-05-13 2015-05-14 Inserm (Institut National De La Sante Et De La Recherche Medicale Method for the diagnosis of early rheumatoid arthritis
US10132817B2 (en) 2011-07-12 2018-11-20 Rowan University Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
WO2013063010A1 (en) * 2011-10-26 2013-05-02 Nuclea Biotechnologies, Inc. Usp2a peptides and antibodies
WO2014020357A1 (en) * 2012-08-02 2014-02-06 Sense Proteomic Limited Auto-antigen biomarkers for lupus
WO2014038622A1 (en) * 2012-09-05 2014-03-13 国立大学法人大阪大学 Biomarker for autoimmune diseases
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
CN105308455B (en) * 2013-03-14 2019-04-09 伊穆科Gti诊治股份有限公司 Method and composition for diagnosing pre-eclampsia
IL293948A (en) * 2013-10-21 2022-08-01 Dyax Corp Diagnosis and treatment of autoimmune diseases
WO2015101988A1 (en) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
ES2731908T3 (en) * 2014-03-13 2019-11-19 Inst Nat Sante Rech Med Diagnostic methods for lupus
US10258764B2 (en) * 2014-07-30 2019-04-16 Covidien Lp Opening system for improving catheter delivery
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
WO2016115256A1 (en) * 2015-01-13 2016-07-21 Quanterix Corporation Methods relating to improving accuracy of capture object-based assays
WO2016128348A1 (en) * 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
WO2016139659A1 (en) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
WO2016205416A1 (en) * 2015-06-15 2016-12-22 uBiome, Inc. Method and system for sequencing in characterization of antibody binding behavior
EP3390700A4 (en) 2015-12-14 2019-12-18 Rowan University Early-stage alzheimer's disease autoantibody biomarkers, target antigens and diagnostic uses thereof
US10612075B2 (en) * 2015-12-28 2020-04-07 PathogenDX Inc Microarray based multiplex pathogen analysis and uses thereof
US11542498B2 (en) * 2015-12-28 2023-01-03 Pathogendx, Inc. Microarray based multiplex pathogen analysis and uses thereof
JP2019526786A (en) 2016-06-20 2019-09-19 ヘルステル・インコーポレイテッドＨｅａｌｔｈｔｅｌｌ Ｉｎｃ． Methods for diagnosis and treatment of autoimmune diseases
US11747334B2 (en) 2016-06-20 2023-09-05 Cowper Sciences Inc. Methods for differential diagnosis of autoimmune diseases
US11359112B2 (en) 2016-11-09 2022-06-14 Cowper Sciences Inc. Coatings with tunable amine density
CA3043264A1 (en) 2016-11-11 2018-05-17 Healthtell Inc. Methods for identifying candidate biomarkers
EP3392656A1 (en) 2017-04-20 2018-10-24 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
AU2018289396A1 (en) * 2017-06-19 2020-02-06 Healthtell Inc. Immunosignatures for differential diagnosis
CA3003032A1 (en) * 2018-04-27 2019-10-27 Nanostics Inc. Methods of diagnosing disease using microflow cytometry
US11644463B2 (en) * 2019-08-30 2023-05-09 Euroimmun Medizinische Labordiagnostika Ag Detection of an autoantibody
JP2023504674A (en) * 2019-12-02 2023-02-06 テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション Combinatorial MAP antibody test for detection and diagnosis
CN114414812B (en) * 2020-12-21 2022-09-20 华中科技大学同济医学院附属同济医院 Application of biomarker combination in preparation of reagent for diagnosing fulminant myocarditis and medicine for fulminant myocarditis
CA3151417A1 (en) * 2021-03-25 2022-09-25 Euroimmun Medizinische Labordiagnostika Ag Method and means for detecting an autoantibody
WO2023016454A1 (en) * 2021-08-12 2023-02-16 The University Of Hong Kong Materials and methods to comprehensively define adaptive immune responses
CN114159457B (en) * 2021-12-03 2023-08-22 温州医科大学 Long-chain non-coding RNA, binding protein and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4357112B2 (en) 1997-10-14 2009-11-04 ルミネックス コーポレイション Precise fluorescent dyed particles and methods for making and using the same
JP3468750B2 (en) 1998-01-22 2003-11-17 ルミネックス コーポレイション Microparticles with multiple fluorescent signals
JP4215397B2 (en) 1998-05-14 2009-01-28 ルミネックス コーポレイション Multiple analyte diagnostic system
US6306610B1 (en) 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
ES2223705T3 (en) 1999-04-28 2005-03-01 Board Of Regents, The University Of Texas System COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER THROUGH INHIBITION SELECTIVE OF VEGF.
EP1794589A4 (en) * 2004-09-15 2010-03-17 Protometrix Inc Protein arrays and methods of use thereof

Also Published As

Publication number Publication date
JP2010510528A (en) 2010-04-02
US20120004130A1 (en) 2012-01-05
WO2008064336A2 (en) 2008-05-29
US20080254482A1 (en) 2008-10-16
EP2089712A4 (en) 2010-09-22
WO2008064336A9 (en) 2008-07-31
EP2089712A2 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
WO2008064336A8 (en) Autoimmune disease biomarkers
EP2089722A4 (en) Biomarkers
GB0617605D0 (en) Biomarkers
AU2006100046A4 (en) HealthyScan
AU2006100590A4 (en) Freed
AU2006100609A4 (en) Best Computer Parts
AU2006904747A0 (en) Void former
AU2006906118A0 (en) Void former
GB0610030D0 (en) Biomarkers
GB0607710D0 (en) Biomarkers
AU2006100519A4 (en) buzzmeband
AU2006100335A4 (en) mFlight
AU2006100332A4 (en) MaxVBrush
AU2006100313A4 (en) mSkill
AU2006100798A4 (en) Sitewatch
AU2006100750A4 (en) Forkslippers
AU2006100314A4 (en) mAlert
AU2006100425A4 (en) Mcricket
AU2006100285A4 (en) Pro-lifter
AU2006100606A4 (en) SportingWebPortal
AU2006100418A4 (en) Mflowers
AU2006100416A4 (en) Mwatch1
AU2006100381A4 (en) mTerminator
AU2006100317A4 (en) mInstant
AU2006100510A4 (en) Msurf

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07868834

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009538516

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007868834

Country of ref document: EP